Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | MYL7 |
Upstream (Parents) |
---|
(<<) IGLV2-11///IGLV2-18///IGLV2-23 → MYL7 |
(<<) CXCL10 → MYL7 |
(<<) HLA-DOB → MYL7 |
(<<) C3orf14 → MYL7 |
(<<) MAGEB2 → MYL7 |
(<<) UBE2L6 → MYL7 |
(<<) PSMB9 → MYL7 |
Downstream (Children) |
---|
MYL7 → FAM135A (>>) |
MYL7 → C3orf14 (>>) |
MYL7 → HCN2 (>>) |
MYL7 → IFNA17 (>>) |
MYL7 → CPA4 (>>) |
MYL7 → HIST1H2AB (>>) |